
StemCell Institute — Investor Relations & Filings
StemCell Institute Inc. is a private cord blood bank established in 1999. The company specializes in the collection, processing, and long-term cryopreservation of stem cells from umbilical cord blood and umbilical cord tissue. Its services are targeted at expectant parents who wish to store these biological materials for potential future use in regenerative medicine and cell therapies for their child or family members. The company operates a state-of-the-art cell processing center and a large-scale cryopreservation facility. It is the largest private cord blood bank in its domestic market, holding over 99% market share and storing more than 80,000 units. StemCell Institute is the only private bank in its region to have released stored units for clinical applications, including treatments for conditions such as leukemia and cerebral palsy. The company is ISO 9001 certified.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 自己株券買付状況報告書(法24条の6第1項に基づくもの) | 2025-12-01 | Japanese | |
| 確認書 | 2025-11-14 | Japanese | |
| 半期報告書-第27期(2025/04/01-2026/03/31) | 2025-11-14 | Japanese | |
| 自己株券買付状況報告書(法24条の6第1項に基づくもの) | 2025-11-04 | Japanese | |
| 自己株券買付状況報告書(法24条の6第1項に基づくもの) | 2025-10-01 | Japanese | |
| 自己株券買付状況報告書(法24条の6第1項に基づくもの) | 2025-09-01 | Japanese |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 8953930 | 自己株券買付状況報告書(法24条の6第1項に基づくもの) | 2025-12-01 | Japanese | ||
| 8318037 | 確認書 | 2025-11-14 | Japanese | ||
| 8318010 | 半期報告書-第27期(2025/04/01-2026/03/31) | 2025-11-14 | Japanese | ||
| 8070504 | 自己株券買付状況報告書(法24条の6第1項に基づくもの) | 2025-11-04 | Japanese | ||
| 7943254 | 自己株券買付状況報告書(法24条の6第1項に基づくもの) | 2025-10-01 | Japanese | ||
| 7856561 | 自己株券買付状況報告書(法24条の6第1項に基づくもの) | 2025-09-01 | Japanese | ||
| 7859626 | 自己株券買付状況報告書(法24条の6第1項に基づくもの) | 2025-08-01 | Japanese | ||
| 7242232 | 自己株券買付状況報告書(法24条の6第1項に基づくもの) | 2025-07-01 | Japanese | ||
| 7248677 | 臨時報告書 | 2025-06-26 | Japanese | ||
| 7253208 | 内部統制報告書-第26期(2024/04/01-2025/03/31) | 2025-06-24 | Japanese | ||
| 7253197 | 確認書 | 2025-06-24 | Japanese | ||
| 7253194 | 有価証券報告書-第26期(2024/04/01-2025/03/31) | 2025-06-24 | Japanese | ||
| 7260727 | 自己株券買付状況報告書(法24条の6第1項に基づくもの) | 2025-06-02 | Japanese | ||
| 7265486 | 自己株券買付状況報告書(法24条の6第1項に基づくもの) | 2025-05-01 | Japanese | ||
| 7268778 | 自己株券買付状況報告書(法24条の6第1項に基づくもの) | 2025-04-01 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Other human health activities n.e.c
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
EC Healthcare
Leading non-hospital medical service provider specializing …
|
2138 | HK | Human health and social work ac… |
|
EDX Medical Group Plc
Develops digital diagnostic products for oncology, cardiolo…
|
EDX | GB | Human health and social work ac… |
|
Enhabit, Inc.
A provider of home health and hospice services using techno…
|
EHAB | US | Human health and social work ac… |
|
ENSIGN GROUP, INC
Healthcare provider of post-acute care, skilled nursing, an…
|
ENSG | US | Human health and social work ac… |
|
EUCALIA Inc.
Offers management support and digital transformation soluti…
|
286A | JP | Human health and social work ac… |
|
Euromedis Groupe
Designs, manufactures, and distributes medical equipment an…
|
ALEMG | FR | Human health and social work ac… |
|
EXACT SCIENCES CORP
A molecular diagnostics company providing tests for cancer …
|
EXAS | US | Human health and social work ac… |
|
EXAGEN INC.
Rheumatology lab providing advanced tests for complex autoi…
|
XGN | US | Human health and social work ac… |
|
FALCO HOLDINGS Co.,Ltd.
Offers clinical testing, dispensing pharmacy operations, an…
|
4671 | JP | Human health and social work ac… |
|
Fangzhou Inc.
Leading online platform specializing in chronic disease man…
|
6086 | KY | Human health and social work ac… |
StemCell Institute via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/14298/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=14298 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=14298 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=14298 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 14298}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for StemCell Institute (id: 14298)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.